La Universidad de Wisconsin-Madison (UW-Madison) será una de las 25 instituciones que estudiarán el desarrollo temprano del cerebro y comportamiento, y el impacto de la exposición temprana a substancias – como opioides – y estresores sociales en niños e infantes. Esta nueva iniciativa, Cerebro y Desarrollo Infantil Saludable (HBCD, en inglés), es liderada por los Institutos Nacionales de Salud (NIH, en inglés) y el Helping to End Addiction Long-termSM Initiative of the National Institutes of Health (NIH HEAL InitiativeSM).
NIH
Stem cell project to create new model to study brain development and Down syndrome
Waisman Center researchers are creating a new approach to study how changes to brain development in the womb result in intellectual disability in people with Down syndrome.
UW-Madison is key site on landmark study focused on early childhood brain development and the impact of substance abuse and stress in infants and young children
The University of Wisconsin-Madison will be one of 25 sites to study early brain and behavior development and the impact of early exposure to substances – such as opioids – and social stressors in infants and young children.
NIH MERIT Award advances fetal alcohol research at UW-Madison
Susan Smith, a professor of nutritional sciences at the University of Wisconsin-Madison, has received a prestigious MERIT award from the National Institutes of Health
HHS Secretary Thompson visits Waisman
On Friday, September 7, HHS Secretary Tommy Thompson paid a visit to the Waisman Center. He was on campus in connection with the groundbreaking for the new Learning Center and asked to tour the new …